BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35091179)

  • 1. Diagnosis of giant cell-rich bone tumors on core needle biopsy: A practical approach.
    Jager L; Johnson DN; Sukhanova M; Streich L; Chapa AR; Alexiev BA
    Pathol Res Pract; 2022 Mar; 231():153777. PubMed ID: 35091179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroblastoma of foot bones; a clinicopathological study of 29 cases confirming the diagnostic utility of H3K36M and H3G34W antibodies at an uncommon site.
    Tariq MU; Din NU; Qureshi MB; Park YK
    Ann Diagn Pathol; 2023 Aug; 65():152135. PubMed ID: 37075609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location.
    Agaram NP; LeLoarer FV; Zhang L; Hwang S; Athanasian EA; Hameed M; Antonescu CR
    Hum Pathol; 2014 Jun; 45(6):1147-52. PubMed ID: 24742829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
    Hegde V; Burke ZDC; Park HY; Zoller SD; Johansen D; Kelley BV; Levine B; Motamedi K; Federman NC; Seeger LL; Nelson SD; Bernthal NM
    Clin Orthop Relat Res; 2018 Mar; 476(3):568-577. PubMed ID: 29529643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP6 gene rearrangement differentiates primary paranasal sinus solid aneurysmal bone cyst from other giant cell-rich lesions: report of a rare case.
    Li HR; Tai CF; Huang HY; Jin YT; Chen YT; Yang SF
    Hum Pathol; 2018 Jun; 76():117-121. PubMed ID: 29217425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
    Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
    Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
    Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of fine-needle aspiration and core biopsy with touch preparation in the diagnosis of renal lesions.
    Scanga LR; Maygarden SJ
    Cancer Cytopathol; 2014 Mar; 122(3):182-90. PubMed ID: 24353131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary bone tumors: percutaneous needle biopsy. Radiologic-pathologic study of 222 biopsies.
    Ayala AG; Zornosa J
    Radiology; 1983 Dec; 149(3):675-9. PubMed ID: 6580673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant Cell-Rich Tumors of Bone.
    Hartmann W; Harder D; Baumhoer D
    Surg Pathol Clin; 2021 Dec; 14(4):695-706. PubMed ID: 34742488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of touch preparations on core needle biopsies.
    Tong LC; Rudomina D; Rekhtman N; Lin O
    Cancer Cytopathol; 2014 Nov; 122(11):851-4. PubMed ID: 24946755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time polymerase chain reaction analysis of MDM2 and CDK4 expression using total RNA from core-needle biopsies is useful for diagnosing adipocytic tumors.
    Sasaki T; Ogose A; Kawashima H; Hotta T; Hatano H; Ariizumi T; Umezu H; Ohashi R; Tohyama T; Tanabe N; Endo N
    BMC Cancer; 2014 Jun; 14():468. PubMed ID: 24965044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of "myositis ossificans-like lesions" are the early phases in the formation of soft-tissue aneurysmal bone cyst.
    Sukov WR; Franco MF; Erickson-Johnson M; Chou MM; Unni KK; Wenger DE; Wang X; Oliveira AM
    Skeletal Radiol; 2008 Apr; 37(4):321-7. PubMed ID: 18265974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.
    Oliveira AM; Perez-Atayde AR; Inwards CY; Medeiros F; Derr V; Hsi BL; Gebhardt MC; Rosenberg AE; Fletcher JA
    Am J Pathol; 2004 Nov; 165(5):1773-80. PubMed ID: 15509545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.